Factors influencing on development of COVID-19 pneumonia and association with oral anti-diabetic drugs in hospitalized patients with diabetes mellitus

Association between comorbid diabetes mellitus and prognosis of patients with sepsis in the intensive care unit: a retrospective cohort study

(2021) Shan Lin et al.   Annals of Translational Medicine

Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study

(2021) Matthieu Wargny et al.   DIABETOLOGIA

Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies

(2021) Darrell O. Ricke   Frontiers in Immunology

COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms

(2021) Robert W. Malone et al.   Frontiers in Pharmacology

COVID-19 pandemic, coronaviruses, and diabetes mellitus

(2020) Ranganath Muniyappa et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication

(2020) Yuchen Chen et al.   DIABETES CARE

Exposure to DPP ‐4 inhibitors and COVID ‐19 among people with type 2 diabetes. A case–control study

(2020) Gian Paolo Fadini et al.   DIABETES OBESITY & METABOLISM

COVID-19 and diabetes: Can DPP4 inhibition play a role?

(2020) Gianluca Iacobellis   DIABETES RESEARCH AND CLINICAL PRACTICE

COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications

(2020) Ilaria Barchetta et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

DPP4 inhibition: preventing SARS‐CoV ‐2 infection and/or progression of COVID ‐19?

(2020) Rocky Strollo et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Kidney disease is associated with in-hospital death of patients with COVID-19

(2020) Yichun Cheng et al.   KIDNEY INTERNATIONAL

Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: a meta-analysis of observational studies

(2020) Alessandro Mantovani et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Is DPP4 inhibition a comrade or adversary in COVID-19 infection

(2020) Rinkoo Dalan   DIABETES RESEARCH AND CLINICAL PRACTICE

Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes

(2020) Xu Cheng et al.   Cell Metabolism

Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study

(2020) Sebastiano Bruno Solerte et al.   DIABETES CARE

Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy

(2020) Marco Mirani et al.   DIABETES CARE

Sodium‐glucose co‐transporter‐2 inhibitors and susceptibility to COVID ‐19: A population‐based retrospective cohort study

(2020) Christopher Sainsbury et al.   DIABETES OBESITY & METABOLISM

Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections

(2020) Kristina Schlicht et al.   INTERNATIONAL JOURNAL OF OBESITY

Clinical Characteristics and Risk Factors for Mortality in Very Old Patients Hospitalized with COVID-19 in Spain

(2020) Jose-Manuel Ramos-Rincon et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

(2020) Luis M. Pérez-Belmonte et al.   BMC Medicine

Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection

(2020) Jiya Sun et al.   Frontiers in Microbiology

What doesn't kill you makes you stranger: Dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands

(2019) Ahmed M. Elmansi et al.   PHARMACOLOGY & THERAPEUTICS

DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice

(2018) Takeshi Kawasaki et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

The Effect of Short-Term Hyperglycemia on the Innate Immune System

(2016) Nagham Jafar et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology

(2016) Anneleen Mortier et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors

(2014) Erin E. Mulvihill et al.   ENDOCRINE REVIEWS

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26

(2013) Guangwen Lu et al.   NATURE

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

(2013) V. Stalin Raj et al.   NATURE

Use of Dipeptidyl Peptidase-4 Inhibitors and the Reporting of Infections: A Disproportionality Analysis in the World Health Organization VigiBase

(2011) M. J. Willemen et al.   DIABETES CARE

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

(2010) Debora Williams-Herman et al.   BMC Endocrine Disorders